The effectiveness of 20 μg hepatitis B vaccine used for the prevention of HBV vertical transmission
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The effectiveness of 20 μg hepatitis B vaccine used for the prevention of HBV vertical transmission ; volume:12 ; number:1 ; day:11 ; month:7 ; year:2022 ; pages:1-8 ; date:12.2022
Scientific reports ; 12, Heft 1 (11.7.2022), 1-8, 12.2022
- Urheber
-
Yonghao, Guo
Yanping, Chen
Qiaohua, Dou
Daxing, Feng
Yanyang, Zhang
Dongyang, Zhao
Wanshen, Guo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-15744-z
- URN
-
urn:nbn:de:101:1-2022091409452498763151
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yonghao, Guo
- Yanping, Chen
- Qiaohua, Dou
- Daxing, Feng
- Yanyang, Zhang
- Dongyang, Zhao
- Wanshen, Guo
- SpringerLink (Online service)
Ähnliche Objekte (12)
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
Novel anti-tick vaccine candidates based on HBV capsid-like particles
An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
Hepatitis B vaccine efficacy in HCV vertical infected infants
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
Gewerkschaften: HBV
Fernmeldezentrale - HBV
Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco
DGB-HBV, Stegmeier
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection
Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
Novel anti-tick vaccine candidates based on HBV capsid-like particles
An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
Hepatitis B vaccine efficacy in HCV vertical infected infants
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
Gewerkschaften: HBV
Fernmeldezentrale - HBV
Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco
DGB-HBV, Stegmeier
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection
Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidates
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
Novel anti-tick vaccine candidates based on HBV capsid-like particles
An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation
Telbivudine treatment started in early and middle pregnancy completely blocks HBV vertical transmission
Hepatitis B vaccine efficacy in HCV vertical infected infants
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
Gewerkschaften: HBV
Fernmeldezentrale - HBV
Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco
DGB-HBV, Stegmeier
Development of a therapeutic vaccine against chronic Hepatitis B virus infection in a preclinical model system : Therapeutic vaccine against chronic HBV infection